Positive clinical data validates current Phase 2b clinical trial of isomyosamine as a treatment for chronic inflammation associated with muscle loss BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, ...
Data on the chronic use of opioids following spinal surgery, intensified treatment of high blood pressure after hospital discharge, and assessments of which frailty measures best predict poor outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results